Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RR0600
Host Cell : SU-DHL-4 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RR0600 |
| Description | This cell line is engineered to stably express GFP reporter gene in SU-DHL-4 cells. |
| Target Gene | GFP |
| Host Cell | SU-DHL-4 |
| Host Cell Species | Homo sapiens (Human) |
| Reporter Type | Fluorescent protein |
| Applications |
1. Gene expression studies 2. Protein localization 3. Drug screening and toxicology 4. Live cell imaging |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
The SU-DHL-4 cell line, established in 1982, is a well-characterized model of diffuse large B-cell lymphoma (DLBCL). Initially derived from the lymph node biopsy of a patient with DLBCL, SU-DHL-4 cells have been extensively utilized in research aimed at understanding the pathogenesis and therapeutic responses of DLBCL. These cells exhibit characteristic features of DLBCL, including the expression of B-cell markers and the presence of chromosomal abnormalities commonly observed in this malignancy.
The development of the SU-DHL-4 GFP reporter cell line represents a significant advancement in DLBCL research. This reporter cell line incorporates a green fluorescent protein (GFP) reporter gene into the SU-DHL-4 cellular genome, allowing for the visualization and tracking of specific cellular processes or molecular events in real-time. By exploiting the unique fluorescence properties of GFP, researchers can monitor cellular behaviors, such as proliferation, migration, and apoptosis, in response to various experimental conditions or therapeutic interventions. Additionally, the SU-DHL-4 GFP reporter cell line serves as a valuable tool for high-throughput screening assays and drug discovery efforts targeting DLBCL.
The researchers investigated the impact of Raji-derived extracellular vesicles (Evs) on lymphoma cells, with a focus on proliferation, invasion, autophagy, and apoptosis. Methods included Cell Counting Kit-8 (CCK-8) assays, Transwell experiments, microscopy, Western blotting, and flow cytometry. They analyzed miR-106a expression, downregulated it in Raji cells, and isolated resulting Evs (Evs-in-miR-106a). The binding relationship between miR-106a and Beclin1 was validated through RNA pull-down and dual-luciferase reporter gene assays. Overexpression of Beclin1 in SU-DHL-4 and Farage cells was performed, assessing autophagy and apoptosis in SU-DHL-4 cells. Tumorigenicity assays in nude mice validated the effects of Raji-Evs. Results demonstrated that Raji-Evs promoted lymphoma cell proliferation and invasion by upregulating miR-106a, which was reversed upon miR-106a knockdown. Furthermore, Raji-Evs-carried miR-106a targeted Beclin1, inhibiting autophagy and apoptosis, thus facilitating tumor growth in vivo. This study elucidated the mechanism by which Raji-Evs inhibit lymphoma cell autophagy and apoptosis while promoting cell growth via the miR-106a/Beclin1 axis.
Figure 1. Inhibition of autophagy and apoptosis in SU-DHL-4 cells via the miR-106a/Beclin1 axis was observed, employing TEM, GFP-mRFP-LC3, WB, flow cytometry, and RT-qPCR techniques. (Tang J, et al., 2022)
If similar studies are conducted, the utilization of our GFP Reporter Cell Line - SU-DHL-4 GFP reporter gene cell line would streamline the experimental procedures described. Within a unified cellular model, simultaneous monitoring of autophagy, apoptosis, and related protein expression levels can be achieved. This encompasses fluorescence microscopy for autophagic pathway observation, Western blot analysis for protein expression levels, and RT-qPCR for miRNA and mRNA expression analysis. These advancements simplify the assessment of cellular processes, thereby enhancing experimental efficiency and data coherence.
1. Cellular Imaging: GFP Reporter Cell Line - SU-DHL-4 facilitates real-time visualization of cellular processes such as proliferation and apoptosis.
2. Targeted Therapy Validation: Researchers validate targeted therapy approaches by observing changes in GFP fluorescence intensity in SU-DHL-4 cells harboring specific genetic alterations.
3. Signal Transduction Studies: Intracellular signaling pathways can be elucidated using SU-DHL-4 GFP Reporter Cell Line, enabling the investigation of signaling cascades involved in cancer progression.
4. Personalized Medicine Development: GFP-labeled SU-DHL-4 cells aid in testing personalized treatment strategies by evaluating individualized responses to therapeutic interventions.
5. High-Throughput Assays: Automation-friendly SU-DHL-4 GFP Reporter Cell Line assays enable rapid screening of large compound libraries for drug discovery purposes.
A: Stable transfection methods were utilized to integrate the GFP reporter gene into SU-DHL-4 cells, ensuring stable and sustained expression. Regular monitoring using fluorescence microscopy or flow cytometry confirmed stable GFP expression levels over time.
A: The SU-DHL-4 GFP Reporter Cell Line serves as a valuable tool for studying lymphoma biology, allowing visualization and tracking of SU-DHL-4 lymphoma cells. Its stable GFP expression enables studies on cell proliferation, migration, and response to treatments.
A: The SU-DHL-4 GFP Reporter Cell Line facilitates drug screening assays in lymphoma research, providing a reliable platform for evaluating the efficacy of potential therapeutics. Its stable GFP expression allows for quantitative analysis of drug effects on SU-DHL-4 cell behavior, aiding in the identification of novel treatment candidates.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
From studying tumor microenvironment interactions to evaluating treatment responses, this cell line serves as an invaluable resource for unraveling the complexities of lymphoma biology and developing novel therapeutic strategies. The GFP Reporter Cell Line consistently provides robust signals, ensuring reproducible results and accurate interpretation of experimental outcomes.
The GFP Reporter Cell Line in SU-DHL-4 cells offers bright and clear GFP expression, enabling detailed visualization and tracking of cellular processes in my lymphoma research.
With GFP fluorescence, this cell line facilitates comprehensive investigation of tumor growth, metastasis, and response to therapy, advancing our understanding of lymphoma biology. Its stable GFP expression simplifies experimental workflows, allowing for efficient data collection and analysis in lymphoma research.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.